Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation

Yaron Ilan(Hadassah Academic College), Daniel Shouva(Hadassah Academic College), Elizabeth Naparstek(Hebrew University of Jerusalem), Arnon Nagler(Tel Aviv University), Chaim Brautba(Hadassah Academic College), Shimon Slavin(Hadassah Academic College), Ruth Adler(Hadassah Academic College), Reuven Or(Hebrew University of Jerusalem)
Hepatology
August 1, 1993
10.1002/hep.1840180204
Cited by 120

Related Papers

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
|Blood|1998|1.9k
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
|Blood|1998|1.8k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
|Journal of Clinical Oncology|2013|439